Herti 440 mg

Brand: Herti 440 mg
Composition: Trastuzumab 440 mg
Company: Hetro
Form : Injection
Packing:  1 vail  in 1 box
Share :

Related Products

Herti 440mg is a prescription medication used to treat certain types of breast cancer, including:
  • HER2-positive breast cancer (in combination with chemotherapy)
  • HER2-positive metastatic breast cancer (in combination with chemotherapy)
Composition: Herti 440mg is a single-ingredient product containing Trastuzumab, a humanized monoclonal antibody that targets the human epidermal growth factor receptor 2 (HER2) protein. Mechanism of Action: Trastuzumab works by binding to the HER2 protein on the surface of cancer cells, which inhibits the growth and survival of these cells. Trastuzumab also inhibits the formation of new blood vessels that supply the cancer cells with oxygen and nutrients. Uses: Herti 440mg is used to treat:
  • HER2-positive breast cancer in combination with chemotherapy (in early-stage breast cancer)
  • HER2-positive metastatic breast cancer in combination with chemotherapy (in advanced breast cancer)
Dosage: The recommended dosage of Herti 440mg is:
  • 440mg administered as an intravenous infusion every 3 weeks
  • Continue treatment until disease progression or unacceptable toxicity
Side Effects: Common side effects of Herti 440mg include:
  • Fever
  • Chills
  • Fatigue
  • Headache
  • Nausea
  • Vomiting
  • Diarrhea
  • Increased risk of heart failure
  • Decreased platelet count
  • Decreased white blood cell count
  • Increased risk of bleeding
Recommendation: Herti 440mg is recommended for patients with HER2-positive breast cancer who have not received previous chemotherapy for this condition. Patients should also be advised to monitor their blood counts and liver function regularly during treatment. Important Note: Patients should not take Herti 440mg if they have a history of severe allergic reactions, heart problems, or kidney problems. Patients should also inform their healthcare provider if they have any underlying medical conditions, such as hypertension or thyroid problems, before taking Herti 440mg. Please note that Herti 440mg is not available in all markets and may be approved for different indications and dosages in different regions. It’s worth noting that Herti 440mg is a higher dose of Trastuzumab compared to other products, and it may be used in patients who have not responded to previous treatments or have relapsed after previous treatment. As with any medication, patients should consult with their healthcare provider to determine the appropriate dosage and treatment schedule.

Herti 440mg is a prescription medication used to treat certain types of breast cancer, including:

  • HER2-positive breast cancer (in combination with chemotherapy)
  • HER2-positive metastatic breast cancer (in combination with chemotherapy)

Composition:

Herti 440mg is a single-ingredient product containing Trastuzumab, a humanized monoclonal antibody that targets the human epidermal growth factor receptor 2 (HER2) protein.

Mechanism of Action:

Trastuzumab works by binding to the HER2 protein on the surface of cancer cells, which inhibits the growth and survival of these cells. Trastuzumab also inhibits the formation of new blood vessels that supply the cancer cells with oxygen and nutrients.

Uses:

Herti 440mg is used to treat:

  • HER2-positive breast cancer in combination with chemotherapy (in early-stage breast cancer)
  • HER2-positive metastatic breast cancer in combination with chemotherapy (in advanced breast cancer)

Dosage:

The recommended dosage of Herti 440mg is:

  • 440mg administered as an intravenous infusion every 3 weeks
  • Continue treatment until disease progression or unacceptable toxicity

Side Effects:

Common side effects of Herti 440mg include:

  • Fever
  • Chills
  • Fatigue
  • Headache
  • Nausea
  • Vomiting
  • Diarrhea
  • Increased risk of heart failure
  • Decreased platelet count
  • Decreased white blood cell count
  • Increased risk of bleeding

Recommendation:

Herti 440mg is recommended for patients with HER2-positive breast cancer who have not received previous chemotherapy for this condition. Patients should also be advised to monitor their blood counts and liver function regularly during treatment.

Important Note:

Patients should not take Herti 440mg if they have a history of severe allergic reactions, heart problems, or kidney problems. Patients should also inform their healthcare provider if they have any underlying medical conditions, such as hypertension or thyroid problems, before taking Herti 440mg.

Please note that Herti 440mg is not available in all markets and may be approved for different indications and dosages in different regions.

It’s worth noting that Herti 440mg is a higher dose of Trastuzumab compared to other products, and it may be used in patients who have not responded to previous treatments or have relapsed after previous treatment. As with any medication, patients should consult with their healthcare provider to determine the appropriate dosage and treatment schedule.

We offer a variety of shipping options, including Express Mail Service (EMS), USPS, DHL, FedEx, TNT, UPS, Aramex, Air Cargo, and sea freight.

Terms and Conditions – 

Bulk Orders: You are responsible for any local import duties and taxes in your country.

For Patients: When ordering prescription medicines for personal use, or for a friend or relative, a valid medical practitioner’s script or prescription is required.

Return and Refund Policy: Due to the nature of our products, we cannot accept returns or exchanges once a purchase is made. However, in the event of non-delivery, you are eligible for either a 100% refund or a reshipment of your order.

Herti 440mg is a prescription medication used to treat certain types of breast cancer, including:

  • HER2-positive breast cancer (in combination with chemotherapy)
  • HER2-positive metastatic breast cancer (in combination with chemotherapy)

Composition:

Herti 440mg is a single-ingredient product containing Trastuzumab, a humanized monoclonal antibody that targets the human epidermal growth factor receptor 2 (HER2) protein.

Mechanism of Action:

Trastuzumab works by binding to the HER2 protein on the surface of cancer cells, which inhibits the growth and survival of these cells. Trastuzumab also inhibits the formation of new blood vessels that supply the cancer cells with oxygen and nutrients.

Uses:

Herti 440mg is used to treat:

  • HER2-positive breast cancer in combination with chemotherapy (in early-stage breast cancer)
  • HER2-positive metastatic breast cancer in combination with chemotherapy (in advanced breast cancer)

Dosage:

The recommended dosage of Herti 440mg is:

  • 440mg administered as an intravenous infusion every 3 weeks
  • Continue treatment until disease progression or unacceptable toxicity

Side Effects:

Common side effects of Herti 440mg include:

  • Fever
  • Chills
  • Fatigue
  • Headache
  • Nausea
  • Vomiting
  • Diarrhea
  • Increased risk of heart failure
  • Decreased platelet count
  • Decreased white blood cell count
  • Increased risk of bleeding

Recommendation:

Herti 440mg is recommended for patients with HER2-positive breast cancer who have not received previous chemotherapy for this condition. Patients should also be advised to monitor their blood counts and liver function regularly during treatment.

Important Note:

Patients should not take Herti 440mg if they have a history of severe allergic reactions, heart problems, or kidney problems. Patients should also inform their healthcare provider if they have any underlying medical conditions, such as hypertension or thyroid problems, before taking Herti 440mg.

Please note that Herti 440mg is not available in all markets and may be approved for different indications and dosages in different regions.

It’s worth noting that Herti 440mg is a higher dose of Trastuzumab compared to other products, and it may be used in patients who have not responded to previous treatments or have relapsed after previous treatment. As with any medication, patients should consult with their healthcare provider to determine the appropriate dosage and treatment schedule.

Reviews

There are no reviews yet.

Be the first to review “Herti 440 mg”

Your email address will not be published. Required fields are marked *

Herti 440mg is a prescription medication used to treat certain types of breast cancer, including:

  • HER2-positive breast cancer (in combination with chemotherapy)
  • HER2-positive metastatic breast cancer (in combination with chemotherapy)

Composition:

Herti 440mg is a single-ingredient product containing Trastuzumab, a humanized monoclonal antibody that targets the human epidermal growth factor receptor 2 (HER2) protein.

Mechanism of Action:

Trastuzumab works by binding to the HER2 protein on the surface of cancer cells, which inhibits the growth and survival of these cells. Trastuzumab also inhibits the formation of new blood vessels that supply the cancer cells with oxygen and nutrients.

Uses:

Herti 440mg is used to treat:

  • HER2-positive breast cancer in combination with chemotherapy (in early-stage breast cancer)
  • HER2-positive metastatic breast cancer in combination with chemotherapy (in advanced breast cancer)

Dosage:

The recommended dosage of Herti 440mg is:

  • 440mg administered as an intravenous infusion every 3 weeks
  • Continue treatment until disease progression or unacceptable toxicity

Side Effects:

Common side effects of Herti 440mg include:

  • Fever
  • Chills
  • Fatigue
  • Headache
  • Nausea
  • Vomiting
  • Diarrhea
  • Increased risk of heart failure
  • Decreased platelet count
  • Decreased white blood cell count
  • Increased risk of bleeding

Recommendation:

Herti 440mg is recommended for patients with HER2-positive breast cancer who have not received previous chemotherapy for this condition. Patients should also be advised to monitor their blood counts and liver function regularly during treatment.

Important Note:

Patients should not take Herti 440mg if they have a history of severe allergic reactions, heart problems, or kidney problems. Patients should also inform their healthcare provider if they have any underlying medical conditions, such as hypertension or thyroid problems, before taking Herti 440mg.

Please note that Herti 440mg is not available in all markets and may be approved for different indications and dosages in different regions.

It’s worth noting that Herti 440mg is a higher dose of Trastuzumab compared to other products, and it may be used in patients who have not responded to previous treatments or have relapsed after previous treatment. As with any medication, patients should consult with their healthcare provider to determine the appropriate dosage and treatment schedule.

Reviews

There are no reviews yet.

Be the first to review “Herti 440 mg”

Your email address will not be published. Required fields are marked *

Medical Disclaimer

Anteka Pharmacy primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on Anteka Pharmacy. Our mission is to support, not replace, the doctor-patient relationship.
Scroll to Top

Log in

Create an Account

Send Enquiry For Herti 440 mg